UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 5
ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
[ ] Check box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue.
[ ] Form 3 Holdings Reported
[X] Form 4 Transactions Reported
1. Name and Address of Reporting Person(s)
William P. Foley II
336 Bollay Drive
Santa Barbara, CA 93117
2. Issuer Name and Ticker or Trading Symbol
Miravant Medical Technologies (MRVT)
3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary)
4. Statement for Month/Year
12/99
5. If Amendment, Date of Original (Month/Year)
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
[X] Director [ ] 10% Owner
[ ] Officer (give title below) [ ] Other (specify below)
7. Individual or Joint/Group Filing (Check Applicable Line)
[X] Form filed by One Reporting Person
[ ] Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
Table I Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
- ------------------------------------------------------------------------------------------------------------------------------------
1)Title of Security 2)Trans- 3.Trans- 4.Securities Acquired(A) 5)Amount of 6) 7)Nature of
action action or Disposed of (D) Securities Indirect
Date Code A Beneficially D Beneficial
(Month/ or Owned at or Ownership
Day/Year) Code Amount D Price End of Year I
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C><C> <C> <C><C>
Common Stock 30,000 D Direct
Common Stock 09/09/99 (1)P 4 2,500 A $11.0250 I by Corporation
Common Stock 09/10/99 (1)P 4 2,500 A $10.3750 I by Corporation
Common Stock 09/16/99 (1)P 4 2,500 A $9.8750 I by Corporation
Common Stock 09/17/99 (1)P 4 8,000 A $9.7500 I by Corporation
Common Stock 09/17/99 (1)P 4 2,900 A $9.2280 I by Corporation
Common Stock 11/29/99 (1)P 4 2,500 A $12.1300 320,900 I by Corporation
Common Stock 2,000 I by Daughter
Common Stock 2,000 I by Son
Common Stock 1,500 I by Spouse
<CAPTION>
Table II (PART 1) Derivative Securitites Acquired, Disposed of, or Beneficially Owned (Columns 1 through 6)
- ------------------------------------------------------------------------------------------------------------------------------------
1)Title of Derivative 2)Conversion 3)Trans- 4)Trans- 5)Number of Derivative 6)Date Exercisable and
Security or Exercise action action Securities Acquired (A) Expiration Date
Price of Date Code or Disposed of (D)
Derivative
Security Code A D Exercisable Expiration
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
<CAPTION>
Table II (PART 2) Derivative Securitites Acquired, Disposed of, or Beneficially Owned (Columns 1,3 and 7 through 11)
- ------------------------------------------------------------------------------------------------------------------------------------
1)Title of Derivative 3)Trans- 7)Title and Amount 8)Price 9)Number of 10) 11)Nature of
Security action of Underlying of Deri- Derivative Indirect
Date Securities vative Securities D Beneficial
Amount or Security Beneficially or Ownership
Number of Owned at I
- Title Shares End of Year
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
<FN>
Explanation of Responses:
(1)
Owned by Fidelity National Financial, Inc., of which Mr. William P. Foley, II is Chairman and Chief Executive Officer, but disclaims
beneficial ownership.
</FN>
</TABLE>
SIGNATURE OF REPORTING PERSON
/S/ William P. Foley II
- -----------------------
William P. Foley II
DATE 02/01/00
